Efficacy of piperacillin/tazobactam combined with levofloxacin on treatment of lower respiratory tract hospital infection in CCU
Wang Jun
Abstract
Wang Jun
Abstract
OBJECTIVE To evaluate the efficacy and safety of piperacillin/tazobactam combined with levofloxacin in the treatment of lower respiratory tract hospital infection in CCU.METHODS A total of 52 patients treated with piperacillin/tazobactam infusion with a dose of 4.5 g/8 h,combined with levofloxacin with a dose of 0.5 once a day were retrospectively analyzed.RESULTS The total effective rate was 92.3% and the average course of treatment was 11.5 days.Bacterial clearance rate was 84.4%.Adverse reaction incidence was 7.6%.CONCLUSION Piperacillin/tazobactam combined with levofloxacin is effective and safe for lower respiratory tract hospital infection of patients in CCU,and can be used as empirical antibiotics for them.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To evaluate the efficacy and safety of piperacillin/tazobactam combined with levofloxacin in the treatment of lower respiratory tract hospital infection in CCU.METHODS A total of 52 patients treated with piperacillin/tazobactam infusion with a dose of 4.5 g/8 h,combined with levofloxacin with a dose of 0.5 once a day were retrospectively analyzed.RESULTS The total effective rate was 92.3% and the average course of treatment was 11.5 days.Bacterial clearance rate was 84.4%.Adverse reaction incidence was 7.6%.CONCLUSION Piperacillin/tazobactam combined with levofloxacin is effective and safe for lower respiratory tract hospital infection of patients in CCU,and can be used as empirical antibiotics for them.
Key concepts: Levofloxacin, Piperacillin/tazobactam, Piperacillin, Medicine, Tazobactam, Antibiotics, Lower respiratory tract infection, Incidence (geometry)